Tag: Hatch-Waxman Act
Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Explore how the FDA approves generic drugs via the ANDA process, ensuring safety and savings. Learn about bioequivalence standards, GDUFA timelines, and the impact of the Hatch-Waxman Act on your medication.
Medications
Archives
Recent-posts
Prescriber Education Resources: Essential Guides for Doctors on Generic Medications
Jan, 7 2026
Infertility Causes Explained: A Complete Guide
Oct, 22 2025
Furosemide vs Alternatives: Benefits, Risks, and Best Uses
Oct, 7 2025
Top Motilium Alternatives in 2024 for Effective Nausea Relief
Oct, 28 2024
How to Keep Travel Medications Within Shelf Life on Long Trips
Dec, 15 2025